Olomouc, Czechia

Radek Zboril

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 3.9

ph-index = 1


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Radek Zboril: Innovator in Nanotechnology and Biomedical Applications

Introduction

Radek Zboril is a prominent inventor based in Olomouc, Czech Republic. He has made significant contributions to the fields of nanotechnology and biomedical applications, holding three patents that showcase his innovative spirit and technical expertise.

Latest Patents

One of his latest patents is titled "Solar thermoplasmonic nanofurnaces and method for making and using same." This invention features a thermoplasmonic device that includes a titanium film and multiple titanium nitride tube elements. Each tube element is designed with an open top and a titanium nitride bottom, featuring a tubular middle portion that extends from the open top to the bottom. Another notable patent is "Bioavailable dithiocarbamate-metal complex particles, method of preparation and use thereof." This invention involves a particulate form of dithiocarbamate-metal complex combined with at least one blood protein, which is suitable for various therapeutic applications, including cancer treatment and visualization.

Career Highlights

Radek Zboril has had a distinguished career, working at notable institutions such as Palacky University Olomouc and Purdue Research Foundation. His work has significantly advanced the understanding and application of nanotechnology in medicine.

Collaborations

Throughout his career, Zboril has collaborated with esteemed colleagues, including Zdenek Skrott and Martin Mistrik. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Radek Zboril's contributions to nanotechnology and biomedical applications highlight his role as a leading inventor in his field. His innovative patents and collaborative efforts continue to impact the scientific community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…